ONLINE DATABASE SEARCH - HIV-LS-294-MEMO
1. 43214 HIV-LS-294; PUBMED-OI-4/20/2004
Anti-HIV-1 Cycloartanes from Leaves and Twigs of Gardenia thailandica
Tuchinda, P, Saiai, A, Pohmakotr, M, Yoosook, C, Kasisit, J, Napaswat, C, Santisuk, T, and Reutrakul, V
Planta Med 2004. 70(4): 366-70
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15095155&dopt=abstract
2. 43215 HIV-LS-294; PUBMED-OI-4/20/2004
Activator of g protein signaling 3; a gatekeeper of cocaine sensitization and drug seeking
Bowers, MS, McFarland, K, Lake, RW, Peterson, YK, Lapish, CC, Gregory, ML, Lanier, SM, and Kalivas, PW
Neuron 2004. 42(2): 269-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15091342&dopt=abstract
3. 43216 HIV-LS-294; PUBMED-OI-4/20/2004
GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks
MacManus, S, Yates, PJ, Elston, RC, White, S, Richards, N, and Snowden, W
AIDS 2004. 18(4): 651-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15090770&dopt=abstract
4. 43217 HIV-LS-294; PUBMED-OI-4/20/2004
Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
Crommentuyn, KM, Rosing, H, Hillebrand, MJ, Huitema, AD, and Beijnen, JH
J Chromatogr B Analyt Technol Biomed Life Sci 2004. 804(2): 359-367
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15081931&dopt=abstract
5. 43218 HIV-LS-294; PUBMED-OI-4/20/2004
The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors
Tramontano, E, OniDi L, Esposito, F, Badas, R, and La Colla, P
Biochem Pharmacol 2004. 67(9): 1751-1761
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15081874&dopt=abstract
6. 43219 HIV-LS-294; EMBASE-HIV-4/21/2004
Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives*1
Venkatachalam, Taracad K, Mao, Chen, and Uckun, Fatih M
Biochemical Pharmacology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T4P-4C1NHC9-1/2/431317f1fe8f400f006357cd2026a2dd
7. 43220 HIV-LS-294; PUBMED-OI-4/20/2004
CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N(')-diphenylureas
Imamura, S, Kurasawa, O, Nara, Y, Ichikawa, T, Nishikawa, Y, Iida, T, Hashiguchi, S, Kanzaki, N, Iizawa, Y, Baba, M, and Sugihara, Y
Bioorg Med Chem 2004. 12(9): 2295-306
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15080927&dopt=abstract
8. 43221 HIV-LS-294; EMBASE-HIV-4/21/2004
[alpha],[alpha]-Trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells
Wang, Min, Xu, Zhidong, Tu, Pengfei, Yu, Xiaolin, Xiao, Sulong, and Yang, Ming
Bioorganic & Medicinal Chemistry Letters 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4C1FBPN-1/2/da8567b8b54131ee0351d2c7846cb57f
9. 43222 HIV-LS-294; EMBASE-HIV-4/21/2004
Molecular mechanism of dioxolane nucleosides against 3TC resistant M184V mutant HIV
Chong, Youhoon and Chu, Chung K
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4BYWSJK-1/2/4dee203f2c0c94bd07458cbda17a9995
10. 43223 HIV-LS-294; PUBMED-OI-4/20/2004
Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor
Muthumani, K, Wadsworth, SA, Dayes, NS, Hwang, DS, Choo, AY, Abeysinghe, HR, Siekierka, JJ, and Weiner, DB
AIDS 2004. 18(5): 739-48
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15075508&dopt=abstract
11. 43224 HIV-LS-294; EMBASE-HIV-4/21/2004
QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters
Gayen, Shovanlal, Debnath, Bikash, Samanta, Soma, and Jha, Tarun
Bioorganic & Medicinal Chemistry 2004. 12(6): 1493-1503
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BN0DF1-3/2/cd94e2af7fe50155a7f8d151322d3bf5
12. 43225 HIV-LS-294; PUBMED-OI-4/20/2004
Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+)-calanolide A by application of (-)-quinine-catalyzed intramolecular oxo-Michael addition
Sekino, E, Kumamoto, T, Tanaka, T, Ikeda, T, and Ishikawa, T
J Org Chem 2004. 69(8): 2760-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15074925&dopt=abstract
13. 43226 HIV-LS-294; EMBASE-HIV-4/21/2004
Clinical testing for HIV-1 drug resistance
Iafrate, AJohn
Clinical Microbiology Newsletter 2004. 26(5): 33-37
HYPERLINK: http://www.sciencedirect.com/science/article/B6T5D-4C237TT-3/2/53cd7721165a6aeb41ac3059ac9e588e
14. 43227 HIV-LS-294; PUBMED-OI-4/20/2004
Genotypic Analysis of HIV-1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
Kieffer, TL, Finucane, MM, Nettles, RE, Quinn, TC, Broman, KW, Ray, SC, Persaud, D, and Siliciano, RF
J Infect Dis 2004. 189(8): 1452-65
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15073683&dopt=abstract
15. 43228 HIV-LS-294; PUBMED-OI-4/20/2004
HIV protease mutations associated with amprenavir resistance during salvage therapy: importance of I54M
Murphy, MD, Marousek, GI, and Chou, S
J Clin Virol 2004. 30(1): 62-67
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15072756&dopt=abstract
16. 43229 HIV-LS-294; PUBMED-OI-4/20/2004
An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
Puri, A, Rawat, SS, Lin, HM, Finnegan, CM, Mikovits, J, Ruscetti, FW, and Blumenthal, R
AIDS 2004. 18(6): 849-58
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15060432&dopt=abstract
17. 43230 HIV-LS-294; EMBASE-HIV-4/21/2004
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
Carr, Andrew, Workman, Cassy, Carey, Dianne, Rogers, Gary, Martin, Allison, Baker, David, Wand, Handan, Law, Matthew, Samaras, Katherine, Emery, Sean, and Cooper, Prof David A
The Lancet 2004. 363(9407): 429-438
HYPERLINK: http://www.sciencedirect.com/science/article/B6T1B-4BMSWPG-B/2/5d0e2a4d62238a6280c064c2494201a2
18. 43231 HIV-LS-294; PUBMED-OI-4/20/2004
A phenylnorstatine inhibitor binding to HIV-1 protease: geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution
Brynda, J, Rezacova, P, Fabry, M, Horejsi, M, Stouracova, R, Sedlacek, J, Soucek, M, Hradilek, M, Lepsik, M, and Konvalinka, J
J Med Chem 2004. 47(8): 2030-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15056001&dopt=abstract
19. 43232 HIV-LS-294; PUBMED-OI-4/20/2004
Indium-mediated atom-transfer and reductive radical cyclizations of iodoalkynes: synthesis and biological evaluation of HIV-protease inhibitors
Yanada, R, Koh, Y, Nishimori, N, Matsumura, A, Obika, S, Mitsuya, H, Fujii, N, and Takemoto, Y
J Org Chem 2004. 69(7): 2417-22
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15049639&dopt=abstract
20. 43233 HIV-LS-294; PUBMED-OI-4/20/2004
Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics
De La Fuente, C, Maddukuri, A, Kehn, K, Baylor, SY, Deng, L, Pumfery, A, and Kashanchi, F
Curr HIV Res 2003. 1(2): 131-52
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15043199&dopt=abstract
21. 43234 HIV-LS-294; PUBMED-OI-4/20/2004
Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors
Lanier, ER, Ait-Khaled, M, Scott, J, Stone, C, Melby, T, Sturge, G, St, Clair M, Steel, H, Hetherington, S, Pearce, G, Spreen, W, and Lafon, S
Antivir Ther 2004. 9(1): 37-45
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15040535&dopt=abstract
22. 43235 HIV-LS-294; PUBMED-OI-4/20/2004
Synthesis of furoannelated analogues of Emivirine (MKC-442)
Wamberg, M, Pedersen, EB, and Nielsen, C
Arch Pharm (Weinheim) 2004. 337(3): 148-51
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15038059&dopt=abstract
23. 43236 HIV-LS-294; PUBMED-OI-4/20/2004
A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal
Armon-Omer, A, Graessmann, A, and Loyter, A
J Mol Biol 2004. 336(5): 1117-28
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15037073&dopt=abstract
24. 43237 HIV-LS-294; WOS-HIV-4/11/2004
Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein
D'Cruz, OJ, Waurzyniak, B, and Uckun, FM
TOXICOL PATHOL 2004. 32(2): 212-221
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220328500005
25. 43238 HIV-LS-294; WOS-HIV-4/11/2004
Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles
Chatel-Chaix, L, Clement, JF, Martel, C, Beriault, V, Gatignol, A, DesGroseillers, L, and Mouland, AJ
MOL CELL BIOL 2004. 24(7): 2637-2648
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220333800005
26. 43239 HIV-LS-294; WOS-HIV-4/11/2004
Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03
Yim, JH, Kim, SJ, Ahn, SH, Lee, CK, Rhie, KT, and Lee, HK
MAR BIOTECHNOL 2004. 6(1): 17-25
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220334100003
27. 43240 HIV-LS-294; WOS-HIV-4/11/2004
Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions
Svarovskaia, ES, Barr, R, Zhang, XC, Pais, GCG, Marchand, C, Pommier, Y, Burke, TR, and Pathak, VK
J VIROL 2004. 78(7): 3210-3222
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220293600002
28. 43241 HIV-LS-294; WOS-HIV-4/11/2004
Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 tat antigen
Moreau, E, Hoebeke, J, Zagury, D, Muller, S, and Desgranges, C
J VIROL 2004. 78(7): 3792-3796
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220293600058
29. 43242 HIV-LS-294; WOS-HIV-4/11/2004
High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site
Akari, H, Fujita, M, Kao, S, Khan, MA, Shehu-Xhilaga, M, Adachi, A, and Strebel, K
J BIOL CHEM 2004. 279(13): 12355-12362
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220334900043
30. 43243 HIV-LS-294; WOS-HIV-4/11/2004
The NEAT study: A 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients
Rodriguez-French, A, Boghossian, J, Gray, GE, Nadler, JP, Quinones, AR, Sepulveda, GE, Millard, JM, and Wannamaker, PG
JAIDS-J ACQ IMM DEF 2004. 35(1): 22-32
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220326500003
31. 43244 HIV-LS-294; WOS-HIV-4/11/2004
Detection and enumeration of circulating HIV-1-specific memory B cells in HIV-1-infected patients
Fondere, JM, Huguet, MF, Macura-Biegun, A, Baillat, V, Ohayon, V, Reynes, J, and Vendrell, JP
JAIDS-J ACQ IMM DEF 2004. 35(2): 114-119
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220327000002
32. 43245 HIV-LS-294; WOS-HIV-4/11/2004
Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples
Carobene, MG, Rubio, AE, Carrillo, MG, Maligne, GE, Kijak, GH, Quarleri, JF, and Salomon, H
JAIDS-J ACQ IMM DEF 2004. 35(2): 207-209
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220327000018
33. 43246 HIV-LS-294; WOS-HIV-4/11/2004
Anti-HIV effects of chloroquine - Inhibition of viral particle glycosylation and synergism with protease inhibitors
Savarino, A, Lucia, MB, Rastrelli, E, Rutella, S, Golotta, C, Morra, E, Tamburrini, E, Perno, CF, Boelaert, JR, Sperber, K, and Cauda, R
JAIDS-J ACQ IMM DEF 2004. 35(3): 223-232
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220327600002
34. 43247 HIV-LS-294; WOS-HIV-4/11/2004
Fosamprenavir - A novel protease inhibitor and prodrug of amprenavir
Ellis, JM, Ross, JW, and Coleman, CI
FORMULARY 2004. 39(3): 151-+
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220347400006
35. 43248 HIV-LS-294; WOS-HIV-4/11/2004
Characterisation of mutated proteinases derived from HIV-positive patients: Enzyme activity, vitality and inhibition
Kozisek, M, Prejdova, J, Soucek, M, Machala, L, Stankova, M, Linka, M, Bruckova, M, and Konvalinka, J
COLLECT CZECH CHEM C 2004. 69(3): 703-714
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220304500015
36. 43249 HIV-LS-294; WOS-HIV-4/18/2004
HIV - Vaginal microfloras as HIV inhibitors
Clarkson, S
NAT REV MICROBIOL 2003. 1(2): 90-91
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220402500007
37. 43250 HIV-LS-294; WOS-HIV-4/18/2004
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique
Gibellini, D, Vitone, F, Schiavone, P, Ponti, C, La, Placa M, and Re, MC
J CLIN VIROL 2004. 29(4): 282-289
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220447700011
38. 43251 HIV-LS-294; WOS-HIV-4/18/2004
Benefits and limitations of testing for resistance to HIV drugs
Richman, DD
J ANTIMICROB CHEMOTH 2004. 53(4): 555-557
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220487000001
39. 43252 HIV-LS-294; WOS-HIV-4/18/2004
Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases
Rosemond, MJC, St, John-Williams L, Yamaguchi, T, Fujishita, T, and Walsh, JS
CHEM-BIOL INTERACT 2004. 147(2): 129-139
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220413200003
40. 43253 HIV-LS-294; WOS-HIV-4/18/2004
Antiviral inhibition of the HIV-1 capsid protein
Kinde, I, Tang, C, Loeliger, E, and Kyere, S
BIOPHYS J 2004. 86(1): 307A-308A
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187971201579